CLINICAL_TRIALS
trial_result
· 2022-10-17
Clinical Trial Update: Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy [Phase 2]
Summary
Phase 2 trial update on intensive 7-day treatment for PTSD using ketamine combined with exposure therapy; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2022-10-17